-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades RXO to Sell, Lowers Price Target to $19

Benzinga·07/28/2026 15:13:55
Listen to the news
TD Cowen analyst Jason Seidl downgrades RXO (NYSE:RXO) from Hold to Sell and lowers the price target from $24 to $19.